Briplatin and lymphocyte count decreased Patient Reports February 12, 2012

Briplatin Side Effects Report #5605483-7
Briplatin side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 23, 2008. Male patient, 75 years of age, weighting 123.5 lb, was diagnosed with pleural mesothelioma malignant and was treated with Briplatin. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, diarrhoea, lymphocyte count decreased, malignant neoplasm progression, nausea , neutrophil count decreased, platelet count decreased, renal impairment. Briplatin dosage: unknown. During the same period patient was treated with ALIMTA, PANVITAN, MASBLON H, KYTRIL, DECADRON, ZANTAC, FOSMICIN, PRIMPERAN. Patient was hospitalized and became disabled. Patient died on 09/14/2007.

Briplatin Side Effects Report #5608804-4
Briplatin side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 30, 2008. Male patient, 75 years of age, weighting 123.5 lb, was diagnosed with pleural mesothelioma malignant and was treated with Briplatin. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, diarrhoea, lymphocyte count decreased, malignant neoplasm progression, nausea , neutrophil count decreased, platelet count decreased, renal function test abnormal. Briplatin dosage: unknown. During the same period patient was treated with ALIMTA, PANVITAN, MASBLON H, KYTRIL, DECADRON, ZANTAC, FOSMICIN, PRIMPERAN. Patient was hospitalized and became disabled. Patient died on 09/14/2007.

Briplatin Side Effects Report #5508618-X
Briplatin side effect was reported by a Health Professional from JAPAN on Nov 06, 2007. Male patient, 68 years of age, was diagnosed with pleural mesothelioma malignant and was treated with Briplatin. After drug was administered, patient experienced the following side effects: anaemia, lymphocyte count decreased, neutrophil count decreased, platelet count decreased, renal impairment, white blood cell count decreased. Briplatin dosage: unknown. During the same period patient was treated with ALIMTA, PANVITAN, METHYCOBAL. Patient was hospitalized and became disabled. Patient recovered.

Briplatin Side Effects Report #5525285-X
Briplatin side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 21, 2007. Male patient, 67 years of age, weighting 101.4 lb, was diagnosed with pleural mesothelioma malignant and was treated with Briplatin. After drug was administered, patient experienced the following side effects: anaemia, lymphocyte count decreased, myelodysplastic syndrome, neutrophil count decreased, platelet count decreased, renal impairment, white blood cell count decreased. Briplatin dosage: unknown. During the same period patient was treated with ALIMTA, GEMZAR, PANVITAN, CYANOCOBALAMIN. Patient was hospitalized and became disabled. Patient recovered.


Briplatin Side Effects Report #5599882-X
Briplatin side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 18, 2008. Male patient, 67 years of age, weighting 101.4 lb, was diagnosed with pleural mesothelioma malignant and was treated with Briplatin. After drug was administered, patient experienced the following side effects: anaemia, lymphocyte count decreased, malignant neoplasm progression, myelodysplastic syndrome, neutrophil count decreased, platelet count decreased, reflux oesophagitis, renal impairment, white blood cell count decreased. Briplatin dosage: unknown. During the same period patient was treated with PARAPLATIN, ALIMTA, GEMZAR, PANVITAN, CYANOCOBALAMIN, TAKEPRON, KYTRIL, DECADRON. Patient was hospitalized and became disabled. Patient died on 12/07/2007.

Briplatin Side Effects Report #5806846-7
Briplatin side effect was reported by a Health Professional from JAPAN on July 07, 2008. Male patient, 62 years of age, was diagnosed with peritoneal mesothelioma malignant and was treated with Briplatin. After drug was administered, patient experienced the following side effects: blood urea increased, c-reactive protein increased, lymphocyte count decreased, malaise, nausea , neutrophil count decreased, platelet count decreased, renal disorder. Briplatin dosage: unknown. During the same period patient was treated with ALIMTA, PANVITAN, CYANOCOBALAMIN, RILMAZAFONE, TAKEPRON, MOBIC, FENTANYL TRANSDERMAL SYSTEM, MAGMITT. Patient was hospitalized. Patient recovered.